AngioDynamics, Inc. Operating Lease Right-of-Use Assets
AngioDynamics, Inc. (ANGO) had Operating Lease Right-of-Use Assets of $5.05 million as of 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-07-14
- 2026-05-31: Operating Lease, Right-of-Use Asset $5.05M.
- 2026-02-28: Operating Lease, Right-of-Use Asset $5.41M.
- 2025-11-30: Operating Lease, Right-of-Use Asset $5.72M.
- 2025-08-31: Operating Lease, Right-of-Use Asset $3.41M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-05-31 | $5.05M 10-K · filed 2026-07-14 |
| 2026-02-28 | $5.41M 10-Q · filed 2026-04-02 |
| 2025-11-30 | $5.72M 10-Q · filed 2026-01-06 |
| 2025-08-31 | $3.41M 10-Q · filed 2025-10-02 |
| 2025-05-31 | $3.85M 10-K · filed 2026-07-14 |
| 2025-02-28 | $4.30M 10-Q · filed 2025-04-02 |
| 2024-11-30 | $4.80M 10-Q · filed 2025-01-08 |
| 2024-08-31 | $5.31M 10-Q · filed 2024-10-03 |
| 2024-05-31 | $5.80M 10-K · filed 2025-07-18 |
| 2024-02-29 | $3.85M 10-Q · filed 2024-04-09 |
| 2023-11-30 | $4.10M 10-Q · filed 2024-01-08 |
| 2023-08-31 | $4.58M 10-Q · filed 2023-10-05 |
| 2023-05-31 | $5.11M 10-K · filed 2024-07-25 |
| 2023-02-28 | $5.14M 10-Q · filed 2023-03-31 |
| 2022-11-30 | $5.75M 10-Q · filed 2023-01-06 |
| 2022-08-31 | $6.33M 10-Q · filed 2022-10-11 |
| 2022-05-31 | $6.97M 10-K · filed 2023-08-03 |
| 2022-02-28 | $7.59M 10-Q · filed 2022-04-07 |
| 2021-11-30 | $8.16M 10-Q · filed 2022-01-07 |
| 2021-08-31 | $8.77M 10-Q · filed 2021-09-30 |
| 2021-05-31 | $9.38M 10-K · filed 2022-07-22 |
| 2021-02-28 | $9.95M 10-Q · filed 2021-03-31 |
| 2020-11-30 | $9.42M 10-Q · filed 2021-01-08 |
| 2020-08-31 | $9.99M 10-Q · filed 2020-10-07 |
| 2020-05-31 | $10.15M 10-K · filed 2021-07-27 |
| 2020-02-29 | $9.63M 10-Q · filed 2020-04-08 |
| 2019-11-30 | $4.60M 10-Q · filed 2020-01-08 |
| 2019-08-31 | $5.10M 10-Q · filed 2019-10-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |